A number of firms have modified their ratings and price targets on shares of Amrize (NYSE: AMRZ) recently:
- 10/9/2026 – Amrize was given a new $40.00 price target by DA Davidson.
- 10/9/2026 – Amrize had its price target lowered by Royal Bank Of Canada from $48.00 to $32.00. They now have an “underperform” rating on the stock.
- 10/8/2026 – Amrize was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
- 10/5/2026 – Amrize had its price target lowered by Wells Fargo & Company from $44.00 to $40.00. They now have an “equal weight” rating on the stock.
- 10/5/2026 – Amrize had its price target lowered by Truist Financial Corporation from $48.00 to $35.00. They now have a “hold” rating on the stock.
- 10/2/2026 – Amrize had its price target lowered by Citigroup Inc. from $58.00 to $50.00. They now have a “buy” rating on the stock.
- 10/1/2026 – Amrize is now covered by Barclays PLC. They set an “equal weight” rating and a $55.00 price target on the stock.
- 10/1/2026 – Amrize is now covered by Barclays PLC. They set an “equal weight” rating and a $55.00 price target on the stock.
- 9/23/2026 – Amrize had its price target lowered by Deutsche Bank Aktiengesellschaft from $64.00 to $56.00. They now have a “buy” rating on the stock.
- 9/22/2026 – Amrize had its price target lowered by UBS Group AG from $57.00 to $42.00. They now have a “neutral” rating on the stock.
- 9/21/2026 – Amrize had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $60.00 price target on the stock.
- 9/18/2026 – Amrize had its price target lowered by Oppenheimer Holdings, Inc. from $62.00 to $55.00. They now have an “outperform” rating on the stock.
- 9/9/2026 – Amrize had its “equal weight” rating reaffirmed by Wells Fargo & Company. They now have a $44.00 price target on the stock, down from $55.00.
- 9/9/2026 – Amrize was downgraded by Citigroup Inc. from “buy” to “cautious”.
- 9/9/2026 – Amrize was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $44.00 price target on the stock, down from $55.00.
- 9/2/2026 – Amrize was given a new $40.00 price target by William Blair.
- 9/2/2026 – Amrize was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have a $52.00 price target on the stock, down from $57.00.
- 9/2/2026 – Amrize had its “underperform” rating reaffirmed by Bank of America Corporation. They now have a $40.00 price target on the stock, down from $50.00.
- 8/31/2026 – Amrize was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
- 8/24/2026 – Amrize is now covered by DA Davidson. They set a “neutral” rating and a $50.00 price target on the stock.
- 8/24/2026 – Amrize was upgraded by DA Davidson to “hold”.
- 8/19/2026 – Amrize was downgraded by Zacks Research from “hold” to “strong sell”.
- 8/13/2026 – Amrize was upgraded by Weiss Ratings from “sell (d+)” to “hold (c)”.
- 8/12/2026 – Amrize had its price target lowered by Stephens from $65.00 to $54.00. They now have an “overweight” rating on the stock.
- 8/11/2026 – Amrize had its price target lowered by Citigroup Inc. from $66.00 to $58.00. They now have a “buy” rating on the stock.
- 8/10/2026 – Amrize was downgraded by Royal Bank Of Canada from “sector perform” to “underperform”. They now have a $48.00 price target on the stock, down from $60.00.
Amrize Announces Dividend
The company also recently disclosed a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s payout ratio is currently 20.28%.
Insiders Place Their Bets
In other Amrize news, insider Jaime Hill bought 1,500 shares of the stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average cost of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the transaction, the insider owned 29,698 shares in the company, valued at approximately $1,399,369.76. The trade was a 5.32% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Gross acquired 3,568 shares of the stock in a transaction on Tuesday, August 11th. The shares were acquired at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the transaction, the insider directly owned 38,485 shares in the company, valued at $1,793,401. The trade was a 10.22% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders acquired 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is owned by insiders.
Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.
The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.
Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.
Featured Articles
- Five stocks we like better than Amrize
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Amrize Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
